Import Brown Plastic Pharmaceutical Bottle — Buy in Bulk from Supplier in Sri Lanka

The 350ml brown plastic pharmaceutical bottle from Petform Pvt Ltd is manufactured in Colombo, Sri Lanka for the safe storage and dispensing of medical products, supplements, and laboratory reagents. The bottle is constructed from BPA-free plastic with an amber-brown pigmentation that provides UV light protection to light-sensitive contents, a critical requirement for pharmaceutical stability. The 350ml capacity sits within a standard range for oral liquid medications, with cylindrical body geometry and a neck finish compatible with multiple closure systems. Petform Pvt Ltd lists this SKU with various cap options for tamper-evident and child-resistant sealing, though specific thread finish dimensions should be confirmed directly with the supplier.

The material specification cites pharmaceutical-grade HDPE or PET as typical for this application, with the brown colorant being a carbon black or iron oxide masterbatch blend that achieves the specified light-blocking properties. BPA-free formulation is standard for pharmaceutical contact materials, though buyers should request confirmation of compliance with USP Class VI or European Pharmacopoeia 3.1.5 migration limits depending on target market. The wall thickness, typically 0.8-1.2mm for this capacity, determines stacking strength and dimensional stability under temperature cycling. Sri Lankan pharmaceutical packaging manufacturers typically operate under WHO-GMP framework conditions, though facility-specific certification status must be verified with Petform Pvt Ltd directly.

Primary end users include compounding pharmacies, generic pharmaceutical manufacturers, veterinary medicine producers, and dietary supplement packers who require compliant primary packaging for liquid or semi-solid dosage forms. The bottle suits export-oriented production given Sri Lanka's preferential trade access to EU and Indian markets under existing agreements. Buyers should confirm with Petform Pvt Ltd: minimum order quantities, whether tooling is required for custom cap configurations, and whether stability testing data is available for the specific resin batch. FOB Colombo or CIF terms are mentioned as available, though Incoterms 2020 precision and named port of destination require clarification before contract.

Petform Pvt Ltd is headquartered in Colombo, Sri Lanka, with operations centred in the 11670 postal district of the capital city. The company holds a Harbor trust tier designation, the baseline verification level within the platform's supplier classification system, indicating registered business presence without additional audited compliance layers. The supplier's response rate stands at 0.00 percent with zero recorded average response hours, signalling minimal or no engagement through platform-mediated inquiry channels. Buyers should therefore anticipate direct outreach challenges and prioritise telephone or alternate contact methods to establish communication before committing to orders. The supplier's address data confirms Sri Lankan legal entity status, though factory inspection reports and specific manufacturing licence numbers are not disclosed in the available profile.

The listing presents Petform Pvt Ltd as serving pharmaceutical, cosmetic, and food packaging segments with export-quality products, yet the profile lacks substantiation of specific manufacturing certifications, annual production capacity figures, or named client references. No employee count, year of establishment, or revenue scale is available in the source data, and these metrics should not be inferred. The supplier explicitly mentions FDA and ISO certification in its product description; buyers must request current certificate copies, scope statements, and accreditation body details, as these claims are unverified by the platform. The absence of response history suggests Petform Pvt Ltd may prioritise offline trade relationships, a pattern not uncommon among established South Asian packaging converters serving regional pharmaceutical clusters.